Skip to content
Create account to build your panelHelp me choose

PCOS Lab Panel: Tests That Can Help With Diagnosis

By the EllaDx team · Updated November 5, 2026 · 4 min read

For education only, not a diagnosis. Talk to your clinician about your results.

Two women reaching toward each other against a deep blue sky
← Back to Journal

Polycystic Ovary Syndrome (PCOS) affects about 6% to 10% of women of reproductive age, depending on the diagnostic criteria used (Bozdag et al., 2016). Many go undiagnosed: in one community study, about two-thirds of women with PCOS had no diagnosis (March et al., 2010), and in a survey of women with PCOS, one-third reported waiting more than 2 years for one (Gibson-Helm et al., 2017). Lab tests can help with diagnosis and management.

What Is PCOS?

PCOS is a hormonal disorder that can involve:

  • Irregular or absent periods
  • Excess androgens (male hormones), shown by blood tests or by physical signs (Joham et al., 2022)
  • Polycystic ovaries on ultrasound

You don't need all three criteria for diagnosis. Guidelines use two of the three, once other conditions have been ruled out (Legro et al., 2013). In adults, a high AMH level can now stand in for the ultrasound (Teede et al., 2023). Diagnosis can be harder in teens and after menopause (Legro et al., 2013).

Labs a Clinician May Use

Androgen Panel

  • Total Testosterone: Can be elevated in PCOS. A first-line test (Bizuneh et al., 2025)
  • Free Testosterone: The unbound form, and a first-line test that can be more sensitive for detecting excess (Bizuneh et al., 2025)
  • DHEA-S: Adrenal androgen that may be elevated. It may be considered if testosterone tests aren't elevated, but it can be less specific (Bizuneh et al., 2025)

Reproductive Hormones

  • LH and FSH: Elevated LH can be a common feature of PCOS (Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004), but it isn't one of the diagnostic criteria (Legro et al., 2013)
  • Progesterone: Made after ovulation, so it can be low due to anovulation
  • AMH: Can be elevated in PCOS, and it can be used in place of ultrasound in adults (Teede et al., 2023)

Metabolic Tests

  • Fasting Insulin: Insulin resistance can be common in PCOS (Azziz et al., 2016), but fasting insulin isn't one of the diagnostic criteria (Legro et al., 2013)
  • Fasting Glucose and HbA1c: Screen for prediabetes/diabetes. Guidelines advise checking all women with PCOS, and an oral glucose tolerance test may be used (Goodman et al., 2015)
  • Lipid Panel: PCOS can increase cardiovascular risk (Azziz et al., 2016), so guidelines advise checking for high cholesterol (Goodman et al., 2015)

Thyroid Panel

PCOS is a diagnosis of exclusion (Azziz et al., 2016), so a clinician may check your thyroid as part of ruling out other causes of your symptoms.

Understanding Your Results

PCOS is a syndrome, so no single test can diagnose it (Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004). It can look different from person to person, and a clinician reads your labs alongside your periods, symptoms and, in some cases, an ultrasound. Treatment can then be tailored to your concerns and needs (Azziz et al., 2016). Combined birth control pills can lower testosterone and raise SHBG (Zimmerman et al., 2014), so tell your clinician if you take them.

References

  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81(1), 19-25. PMID 14711538
  • Legro, R. S., et al. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 98(12), 4565-4592. PMID 24151290
  • Bozdag, G., et al. (2016). The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction, 31(12), 2841-2855. PMID 27664216
  • March, W. A., et al. (2010). The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction, 25(2), 544-551. PMID 19910321
  • Gibson-Helm, M., et al. (2017). Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism, 102(2), 604-612. PMID 27906550
  • Teede, H. J., et al. (2023). Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 120(4), 767-793. PMID 37589624
  • Bizuneh, A. D., et al. (2025). Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Human Reproduction Update, 31(1), 48-63. PMID 39305127
  • Goodman, N. F., et al. (2015). AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Endocrine Practice, 21(12), 1415-1426. PMID 26642102
  • Azziz, R., et al. (2016). Polycystic ovary syndrome. Nature Reviews. Disease Primers, 2, 16057. PMID 27510637
  • Zimmerman, Y., et al. (2014). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76-105. PMID 24082040
  • Joham, A. E., et al. (2022). Polycystic ovary syndrome. Lancet Diabetes & Endocrinology, 10(9), 668-680. PMID 35934017